A Utah surgeon’s victory in a vaccine fraud case has encouraged other “medical freedom” advocates to consider seeking ...

The drop reflects investors reactions to Pfizer’s new 2026 revenue forecasts, which is set to be between the range of $59.5 billion to $62.5 billion, a decline of $1.5 billion from 2025’s estimated ...

Eli Lilly’s retatrutide exceeds expectations in Phase III, capping off a sparkling 2025 for the obesity titan; an internal ...

New research in mice suggests that reprogramming the liver with mRNA could strengthen vaccination responses and cancer ...

Since the announcements by federal health authorities earlier this year that federal mRNA vaccine funding will be curtailed, ...

A Utah surgeon’s victory in a vaccine fraud case has encouraged other “medical freedom” advocates to consider seeking ...

On July 18, a mild, overcast night in Nairobi, Kenya, a team of President Donald Trump’s top foreign aid advisers ducked into a meeting room at the Tribe Hotel, their luxury accommodations in the city ...

The U.S. has registered over half a million clinical trials since 2000. Here's a look at the business and ethics of human ...

Pfizer ( (PFE)) has provided an announcement. On December 16, 2025, Pfizer announced its financial guidance for the full year 2026, while revising its 2025 revenue guidance to approximately $62.0 ...

While NIH director Jay Bhattacharya focuses on podcasting, his second-in-command is dramatically remaking the agency.

Although development of a jab for the H5N1 strain of avian flu is well under way, other strains are receiving less attention ...